{"id":"https://openalex.org/W2129012919","doi":"https://doi.org/10.1158/1535-7163.mct-07-0393","title":"Characterization of structurally distinct, isoform-selective phosphoinositide 3\u2032-kinase inhibitors in combination with radiation in the treatment of glioblastoma","display_name":"Characterization of structurally distinct, isoform-selective phosphoinositide 3\u2032-kinase inhibitors in combination with radiation in the treatment of glioblastoma","publication_year":2008,"publication_date":"2008-04-01","ids":{"openalex":"https://openalex.org/W2129012919","doi":"https://doi.org/10.1158/1535-7163.mct-07-0393","mag":"2129012919","pmid":"https://pubmed.ncbi.nlm.nih.gov/18413797"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-07-0393","doi":"https://doi.org/10.1158/1535-7163.mct-07-0393","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-07-0393","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009464061","display_name":"Jack S. Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jack S. Chen","raw_affiliation_strings":["1Radiation Oncology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Radiation Oncology, Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026820360","display_name":"Linda J. Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda J. Zhou","raw_affiliation_strings":["1Radiation Oncology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Radiation Oncology, Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057405162","display_name":"Michal Entin\u2010Meer","orcid":"https://orcid.org/0000-0001-9909-5502","observed_orcids":["https://orcid.org/0000-0001-9909-5502"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michal Entin-Meer","raw_affiliation_strings":["1Radiation Oncology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Radiation Oncology, Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064914367","display_name":"Xiaodong Yang","orcid":"https://orcid.org/0000-0001-6895-0713","observed_orcids":["https://orcid.org/0000-0001-6895-0713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaodong Yang","raw_affiliation_strings":["1Radiation Oncology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Radiation Oncology, Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055305396","display_name":"Mila Donker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mila Donker","raw_affiliation_strings":["1Radiation Oncology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Radiation Oncology, Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016747773","display_name":"Zachary A. Knight","orcid":"https://orcid.org/0000-0001-7621-1478","observed_orcids":["https://orcid.org/0000-0001-7621-1478"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zachary A. Knight","raw_affiliation_strings":["2Molecular and Cellular Pharmacology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Molecular and Cellular Pharmacology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073603294","display_name":"William A. Weiss","orcid":"https://orcid.org/0000-0003-2230-9132","observed_orcids":["https://orcid.org/0000-0003-2230-9132"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Weiss","raw_affiliation_strings":["3Neurology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Neurology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079376363","display_name":"Kevan M. Shokat","orcid":"https://orcid.org/0000-0001-8590-7741","observed_orcids":["https://orcid.org/0000-0001-8590-7741"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevan M. Shokat","raw_affiliation_strings":["2Molecular and Cellular Pharmacology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Molecular and Cellular Pharmacology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085032736","display_name":"Daphne Adele Haas-Kogan","orcid":"https://orcid.org/0000-0002-2378-4800","observed_orcids":["https://orcid.org/0000-0002-2378-4800"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daphne Haas-Kogan","raw_affiliation_strings":["1Radiation Oncology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Radiation Oncology, Departments of","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082108617","display_name":"David Stokoe","orcid":"https://orcid.org/0000-0002-6333-5364","observed_orcids":["https://orcid.org/0000-0002-6333-5364"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Stokoe","raw_affiliation_strings":["4Cancer Research Institute, Comprehensive Cancer Center at the University of California at San Francisco, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Cancer Research Institute, Comprehensive Cancer Center at the University of California at San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.9257,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.94957035,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"7","issue":"4","first_page":"841","last_page":"850"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.8413000106811523,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.8413000106811523,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.15320000052452087,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.968999981880188},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.8709999918937683},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.9629999995231628},{"id":"https://openalex.org/keywords/ionizing-radiation","display_name":"ionizing radiation","score":0.7990000247955322},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.8399999737739563},{"id":"https://openalex.org/keywords/ribosomal-protein-s6-phosphorylation","display_name":"S6 phosphorylation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.8669999837875366},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7260000109672546},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.7260000109672546}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7002233862876892},{"id":"https://openalex.org/C2781465904","wikidata":"https://www.wikidata.org/wiki/Q14887700","display_name":"P110\u03b1","level":4,"score":0.6778537631034851},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5850307941436768},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5436810851097107},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.49635058641433716},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4850001037120819},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4711555242538452},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4634746015071869},{"id":"https://openalex.org/C2781322055","wikidata":"https://www.wikidata.org/wiki/Q423725","display_name":"Phosphoinositide 3-kinase","level":4,"score":0.44776755571365356},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.43598079681396484},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.31108564138412476},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18127509951591492}],"mesh":[{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001253","descriptor_name":"Astrocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001253","descriptor_name":"Astrocytes","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002867","descriptor_name":"Chromones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005663","descriptor_name":"Furans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011839","descriptor_name":"Radiation, Ionizing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-07-0393","doi":"https://doi.org/10.1158/1535-7163.mct-07-0393","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-07-0393","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:18413797","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18413797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3708390736","display_name":"PROGRAMS FOR TREATMENT OF MALIGNANT BRAIN TUMORS","funder_award_id":"P01NS042927","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G4176639292","display_name":"PROTEIN KINASE B PATHWAY IN CELL TRANSFORMATION","funder_award_id":"R01CA079548","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5780538108","display_name":null,"funder_award_id":"P01 NS-42927-27A2","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G9000917356","display_name":"Brain Tumor SPORE Grant","funder_award_id":"P50CA097257","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W3625525","https://openalex.org/W1519698040","https://openalex.org/W1600510649","https://openalex.org/W1603334805","https://openalex.org/W1655331233","https://openalex.org/W1972919751","https://openalex.org/W1982768187","https://openalex.org/W1990549862","https://openalex.org/W2010538519","https://openalex.org/W2017165269","https://openalex.org/W2038529685","https://openalex.org/W2042142977","https://openalex.org/W2045604110","https://openalex.org/W2052750950","https://openalex.org/W2059072734","https://openalex.org/W2062173397","https://openalex.org/W2064504873","https://openalex.org/W2075556692","https://openalex.org/W2081566809","https://openalex.org/W2086785010","https://openalex.org/W2091572909","https://openalex.org/W2091736771","https://openalex.org/W2096586826","https://openalex.org/W2100470338","https://openalex.org/W2109252212","https://openalex.org/W2109467838","https://openalex.org/W2112785522","https://openalex.org/W2124593509","https://openalex.org/W2125096000","https://openalex.org/W2131660936","https://openalex.org/W2136676465","https://openalex.org/W2152624764","https://openalex.org/W2168805837","https://openalex.org/W2216966119","https://openalex.org/W2326655300","https://openalex.org/W2415362710","https://openalex.org/W4236009772"],"related_works":["https://openalex.org/W3093915967","https://openalex.org/W3111121291","https://openalex.org/W4317493810","https://openalex.org/W2113102381","https://openalex.org/W1973011428","https://openalex.org/W2064504873","https://openalex.org/W4283365120","https://openalex.org/W2125406050","https://openalex.org/W1988036808","https://openalex.org/W2090220413"],"abstract_inverted_index":{"The":[0,110],"phosphoinositide":[1],"3'-kinase":[2],"(PI3K)-mediated":[3],"signaling":[4,23,42],"pathway":[5,26,43],"plays":[6],"a":[7,48,127,152,173],"key":[8],"role":[9],"in":[10,15,67,91,105,131,147,155,180,192,200],"fundamental":[11],"cellular":[12,17,98,121],"functions":[13],"important":[14],"normal":[16],"homeostasis":[18],"and":[19,32,37,89,100,117],"malignant":[20],"transformation.":[21],"Deregulated":[22],"through":[24],"this":[25],"contributes":[27],"to":[28,35,51,119],"development":[29],"of":[30,54,61,73,84,143,195],"gliomas":[31],"their":[33,68],"resistance":[34],"radiation":[36,108,134,150],"chemotherapy.":[38],"Targeting":[39],"the":[40,58,74,141,144,161,181,193],"PI3K":[41,75,187],"has":[44],"thus":[45],"emerged":[46],"as":[47,125],"promising":[49,190],"approach":[50],"successful":[52],"treatment":[53,163,167,183,194],"gliomas.":[55],"We":[56],"assessed":[57],"radiosensitizing":[59],"potential":[60],"four":[62],"small-molecule":[63],"inhibitors":[64,81,188],"that":[65],"differ":[66],"activities":[69],"against":[70],"specific":[71],"isoforms":[72],"110-kDa":[76],"catalytic":[77],"subunit":[78],"(p110).":[79],"p110alpha":[80,145],"blocked":[82],"phosphorylation":[83],"both":[85],"protein":[86],"kinase":[87],"B/Akt":[88],"S6":[90],"all":[92],"cell":[93],"lines":[94],"examined,":[95],"effectively":[96],"decreased":[97],"proliferation,":[99],"produced":[101],"additive":[102],"cytotoxic":[103],"effects":[104,116,142],"combination":[106,132,148,182,201],"with":[107,133,149,165,202],"therapy.":[109],"p110beta":[111],"inhibitor":[112,146],"exhibited":[113],"limited":[114],"biochemical":[115],"failed":[118],"decrease":[120],"proliferation":[122],"or":[123,130,135],"viability":[124],"either":[126],"single":[128],"agent":[129],"rapamycin.":[136],"In":[137,185],"vivo":[138],"studies":[139],"examining":[140],"indicated":[151],"significant":[153],"reduction":[154],"tumor":[156],"growth":[157],"rate":[158],"induced":[159],"by":[160],"combined":[162],"compared":[164],"each":[166],"modality":[168],"alone.":[169],"This":[170],"translated":[171],"into":[172],"trend":[174],"toward":[175],"prolonged":[176],"time-to-failure":[177],"for":[178],"mice":[179],"group.":[184],"conclusion,":[186],"are":[189],"agents":[191],"glioblastomas,":[196],"especially":[197],"when":[198],"used":[199],"ionizing":[203],"radiation.":[204]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}